-
PurposeInducible expression of GFP and constitutive expression of mCherry
-
Depositing Labs
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 59324 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepFPV25.1
-
Backbone manufacturerAddgene Plasmid #20668
- Backbone size w/o insert (bp) 4764
- Total vector size (bp) 7200
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsNo special growth conditions are required for optimal induction
-
Copy numberUnknown
Gene/Insert 1
-
Gene/Insert namemCherry
-
GenBank ID
- Promoter rpsM
Cloning Information for Gene/Insert 1
- Cloning method Unknown
- 5′ sequencing primer mCherry-R
- 3′ sequencing primer PBAD-R (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert nameEGFP
-
Alt namegfpmut3a
- Promoter Pbad
Cloning Information for Gene/Insert 2
- Cloning method Unknown
- 5′ sequencing primer PBAD-F (Common Sequencing Primers)
Resource Information
-
Addgene Notes
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please note that a ~2.4kb band may appear in restriction digest experiments which represents single-stranded DNA (ssDNA).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pFCcGi was a gift from Sophie Helaine & David Holden (Addgene plasmid # 59324 ; http://n2t.net/addgene:59324 ; RRID:Addgene_59324) -
For your References section:
Identification of salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar typhimurium: implications for rational vaccine design. Figueira R, Watson KG, Holden DW, Helaine S. MBio. 2013 Apr 16;4(2):e00065. doi: 10.1128/mBio.00065-13. 10.1128/mBio.00065-13 PubMed 23592259